Considerations for Systemic Anticoagulation in ESRD-Reference-Cited by-同舟云学术

Considerations for Systemic Anticoagulation in ESRD

Published:2015-05-07 Issue:4 Volume:28 Page:354-362
ISSN:0894-0959
Container-title:Seminars in Dialysis
language:en
Short-container-title:Semin Dial

Author:

Dager William E.¹²³,Tsu Laura V.⁴,Pon Tiffany K.⁵

Affiliation:

1. Department of Clinical Pharmacy; University of California, San Francisco; San Francisco California

2. Departments of Medicine and Pharmaceutical Services; Davis Medical Center; University of California Davis School of Medicine; Sacramento California

3. Department of Pharmacy; Touro Vallejo School of Pharmacy; Vallejo California

4. Department of Pharmacy Practice; Midwestern College of Pharmacy; Glendale Arizona

5. Department of Clinical Pharmacy; School of Pharmacy; University of California San Francisco; San Francisco California

Publisher

Wiley

Subject

Nephrology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/sdi.12376/fullpdf

Reference89 articles.

1. Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis;Zimmerman;Nephrol Dial Transplant,2012

2. Anticoagulant and antiplatelet therapy in patients with chronic kidney disease: risks versus benefits review;Harmon;Curr Opin Nephrol Hypertens,2013

3. Bleeding and thrombotic complications of kidney disease;Pavord;Blood Rev,2011

4. Thrombosis in end-stage renal disease;Casserly;Semin Dial,2003

5. Haemostasis in chronic kidney disease;Lutz;Nephrol Dial Transplant,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complexities and Outcomes of Pulmonary Hypertension in Kidney Transplant Patients: A Comprehensive Review;Turkish Journal of Nephrology;2024-01-05

2. Hemodialysis-Related Complement and Contact Pathway Activation and Cardiovascular Risk: A Narrative Review;Kidney Medicine;2021-07

3. Thrombotic disorders (part 2);South African Medical Journal;2020-02-26

4. Laboratory Monitoring of Parenteral Direct Thrombin Inhibitors;Seminars in Thrombosis and Hemostasis;2017-01-04

5. Evaluation and Management of Pulmonary Hypertension in Kidney Transplant Candidates and Recipients;Transplantation;2017-01